4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-25-041344
Options or other derivatives
- Director acquired 28,346 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Parsey Merdad Director | 2025-04-28 | Grant or award · Stock Option (right to buy) | +28,346 | 28,346 | D: show line 1 in the form |
Loading xslF345X05/tm2513488-2_4seq1.xml…